Healthcare
Live Price
Offline$49.41
+4.73% today
1Y Change
-42.22%
Window
Jun 30, 2025 → Jun 17, 2026
Coverage: 243 bars · Jun 30, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Prestige Consumer Healthcare Inc. (PBH) is a Healthcare stock with a market cap of $2.61B and listed on NYSE. The stock last traded around $49.41 and down 42.2% across the available one-year price window (Jun 30, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +1.1%, EPS growth of +2.6%, a dividend yield of 0.0%. What stands out right now is revenue +1.1%, EPS +2.6%, free cash flow +1.6% with operating margin 29.2% and ROIC 6.7%. Valuation is more restrained than many high-expectation growth names at P/E 14.1 and price/sales 2.4. Stock Foundry combines PBH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
PBH is 62.14 pts behind over the shared 1Y window.
PBH had 34.29 pts deeper max drawdown than SPY.
PBH beat SPY in 0 of 2 calendar years shown and trailed in 2.
PBH
-42.22%
Normalized return
SPY
+19.93%
S&P 500
Excess Return
-62.14 pts
Relative to SPY
PBH Max Drawdown
-43.43%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for PBH and SPY.
| Year | PBH | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -24.63% | +6.71% | -31.34 pts | SPY |
| 2025 | -22.04% | +11.19% | -33.23 pts | SPY |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+1.1%
EPS Growth
+2.6%
Gross Margin
56.4%
Net Margin
16.9%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.